Psoriasis Study #2

A Phase IIa, Randomized, Double-Blind, Placebo Controlled Study to Evalute the Clinical Efficacy, Safety and Pharmacokinetics of Three Different Doses of BMS-582949 Given Orally to Subjects with Moderate to Severe Plaque Psoriasis

We are currently looking for healthy adults with moderate to severe psoriasis to take part in a research study testing an investigational oral medication.
You may qualify if:

• You have moderate to severe acne
• You are a healthy person between the age of 18 and 75
• You are not pregnant, nursing or planning pregnancy (females only).

This is a 24 week study with up to 10 clinic visits and one telephone contact. All study related medication and clinic visits are at no cost. Compensation given to qualified participants.